IndiaOne Finance - Company Dashboard

Governance Classic Home

Mankind Pharma LtdPharmaceuticalsINE634S01028Consolidated₹2318.00+23.00 (+1.00%)Jun-26

Valuation

Market Cap₹95.02K Cr

TTM PE46.49x

Forward PE46.51x

PEG6.87

Book Value₹394.69

P/B5.83x

TTM EPS₹49.49

Fwd EPS₹49.47

TTM Revenue₹14.74K Cr

TTM PAT₹2.07K Cr

TTM EBITDA₹3.83K Cr

TTM EBIT₹2.93K Cr

Last Qtr PAT₹574.09 Cr

Last Qtr EBITDA₹1.06K Cr

Last Qtr EBIT₹830.49 Cr

Profitability

ROE12.68%

ROCE13.79%

TTM NPM14.03%

TTM EBITDA %25.97%

Curr OPM14.09%

Last OPM15.73%

Curr NPM—

Last NPM—

Curr EPS₹13.76

Last EPS₹13.44

Balance sheet

Equity₹41.28 Cr

Reserve₹16.26K Cr

Total Debt₹6,375.54 Cr

D/E0.39x

Interest %19.16%

Curr Interest₹109.98 Cr

Price / range

Close₹2300.70

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.03%

1W+1.80%

1M-3.01%

3M-3.62%

6M+10.25%

1Y-12.79%

2Y-4.01%

3Y+32.61%

5Y—

Diwali+6.36%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	2,964.05+16.6%	2,581.82	2,632.68	2,608.78	2,541.36	10,421.20
Other Income	33.96	126.70	56.52	77.67	64.22	326.10
Total Income	2,998.01+15.1%	2,708.52	2,689.20	2,686.45	2,605.58	10,747.28
Interest	94.95	125.28	138.37	147.20	146.70	562.21
Expenditure	-2,241.44-6.1%	-1,897.69	-2,100.49	-2,161.82	-2,111.92	-8,326.04
PBDT	0	0	0	0	0	0
EBITDA	928.58+38.0%	918.84	778.25	693.19	673.07	3,085.94
Depreciation	-111.02	-109.43	-107.69	-99.03	-96.93	-428.57
EBIT	817.56+41.9%	809.41	670.56	594.16	576.14	2,657.37
PBT	756.57+53.3%	788.01	505.29	524.63	493.66	2,315
Tax	-198.08	-74.40	-55.82	-65.73	-80.90	-277.44
Equity	41.30	41.28	41.28	0	41.27	41.28
OPM	25.24	29.09	18.79	20.11	18.95	21.54
Net Profit	558.49+35.3%	713.61	449.47	458.90	412.76	2,037.56
NPM	18.63	26.35	16.71	17.59	15.84	18.96
EPS	13.53+35.3%	17.29	10.89	11.12	10	49.37

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	10,421.18+9.7%	9,497.80+2.5%	9,264.81+14.0%	8,127.15
Other Income	326.10	493.21	266.64	162.78
Total Income	10,747.28+7.6%	9,991.01+4.8%	9,531.45+15.0%	8,289.94
Expenditure	-8,326.04-8.3%	-7,685.02-5.7%	-7,271.88-8.1%	-6,727.10
Interest	-562.21	-371.76	-14.57	-27.75
PBDT	0	0	0	0
EBITDA	3,085.92+20.4%	2,562.55+10.2%	2,325.11+37.0%	1,697.38
Depreciation	-428.57	-378.01	-317.61	-269.58
EBIT	2,657.35+21.6%	2,184.54+8.8%	2,007.50+40.6%	1,427.80
PBT	2,315+0.4%	2,305.99+2.1%	2,259.57+44.6%	1,562.84
Tax	-277.44	-421.74	-436.16	-314.58
Equity	41.28	41.26	0	0
OPM (%)	21.54	23.08	24.00	19.00
Net Profit	2,037.56+4.7%	1,945.48+6.7%	1,823.41+46.1%	1,248.26
NPM (%)	18.96	19.47	19.00	15.00
EPS (Rs)	49.37-47.9%	94.80+108.3%	45.52+46.1%	31.16
CEPS	49.30	94.63	45.45	31.16

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	4,030.59+12.9%	3,442.93	3,567.20	3,697.16	3,570.35	14,277.60
Other Income	45	114.29	72.75	91.87	79.88	358.79
Total Income	4,075.59+11.7%	3,557.22	3,639.95	3,789.03	3,650.23	14,636.43
Interest	109.98	141.75	157.20	169.68	170.65	639.28
Expenditure	-3,310.08-6.3%	-2,877.88	-3,027.57	-3,167.33	-3,112.91	-12,185.69
PBDT	0	0	0	0	0	0
EBITDA	1,056.19+24.7%	929.88	919.43	921.33	846.77	3,617.37
Depreciation	-225.70	-223.08	-222.60	-221.82	-218.68	-886.18
EBIT	830.49+32.2%	706.80	696.83	699.51	628.09	2,731.19
PBT	765.51+42.5%	656.18	505.79	621.70	537.32	2,320.99
Tax	-195.36	-99.75	-95.12	-103.84	-95.87	-394.58
Equity	41.30	41.28	0	0	41.27	41.28
OPM	18.78	18.45	13.90	16.41	14.72	15.86
Net Profit	574.09+29.1%	559.42	413.88	520.18	444.62	1,938.10
NPM	14.09	15.73	11.37	13.73	12.18	13.24
EPS	13.76+29.6%	13.44	9.90	12.39	10.62	46.35

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24
Revenue	14,277.64+17.0%	12,207.44+18.1%	10,334.78
Other Income	358.79	536.79	280.86
Total Income	14,636.43+14.8%	12,744.23+20.1%	10,615.63
Expenditure	-12,185.69-19.0%	-10,240.14-24.4%	-8,231.49
Interest	-639.28	-429.41	-33.53
PBDT	0	0	0
EBITDA	3,617.41+19.9%	3,017.93+19.0%	2,535.07
Depreciation	-886.18	-621.22	-398.25
EBIT	2,731.23+14.0%	2,396.71+12.2%	2,136.82
PBT	2,320.99-7.3%	2,504.09+5.0%	2,384.15
Tax	-394.58	-509.74	-457.59
Equity	41.28	41.26	0
OPM (%)	15.86	19.65	22.46
Net Profit	1,938.10-3.6%	2,011.12+3.6%	1,941.77
NPM (%)	13.24	15.78	18.29
EPS (Rs)	46.35-5.9%	49.28+3.2%	47.75
CEPS	46.28	49.19	47.68

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Interim Dividend	1	08 Aug 2025

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split